USE OF HYDROPHILIC CAROTENOIDS FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMENT OF DISEASES HAVING AN OXYGENATION MECHANISM

摘要

Lutein and other hydrophilic carotenoids are disclosed for use in treatment by therapy or prophylaxis of diseases having an oxygenation mechanism. The carotenoids disclosed are especially useful in treatment of coronary heart disease and may be combined with e.g. aspirin.